未登录 分享 收藏
分享 收藏
分享 收藏
Global Stress Responses Identify the Functionally Divergent Regulators Required for Candida auris Commensalism and Pathogenicity 全球应激反应鉴定了念珠菌属 auris 共生和致病性所需的功能分化调节因子 Xu, Chaoyue; Xu, Wanxing; Yuan, Yushun; Chen, Xiaoqing; Mo, Ouyang; Yin, Zhe; Huang, Xinhua; Wang, Yuanyuan; Hu, Lingfei; Xue, Wenwen; Zou, Yun; Zhang, Luyao; Li, Kunlin; Tian, Yueru; Liu, Jihong; Xiong, Sichu; Wu, Lei; Dong, Yanmei; Chen, Guangsheng; Zhang, Yuping; Zhou, Zili; Guan, Ming; Huang, Xiaotian; He, Zhiyi; Zhong, Lin; Zeng, Lingbing; Hao, Pei; Zheng, Xiaoqi; Chen, Changbin; Liu, Ning-ning; Zhou, Dongsheng 分享 收藏
分享 收藏
分享 收藏
Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15 Han, Chenglin; Yang, Bin; Deng, Yuxuan; Hu, Peng; Hu, Bintao; Liu, Xiaming; Wang, Tao; Li, Chengbao; Liu, Jihong; Yuan, Huixing 分享 收藏
分享 收藏
PLIN2 Promotes Lipid Accumulation in Ascites-Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling PLIN2通过HIF1α/SPP1信号通路促进腹水相关巨噬细胞中的脂质积累及卵巢癌进展。 Luo, H; She, XL; Zhang, YB; Xie, BF; Zhang, SB; Li, QQ; Zhou, YY; Guo, S; Zhang, SS; Jiang, YH; Dong, YY; He, JZ; Wang, LJ; Zhang, QQ; Zhuang, Y; Deng, PX; Wang, F; Liu, JH; Chen, X; Nie, HL; He, HH 分享 收藏
Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer Wang, Yulin; Yang, Yunjie; Guo, Binghong; Li, Xiaoyan; Tuersun, Renakezi; Cao, Ye; Li, Jundong; Liu, Jihong; Li, Su; Liu, Tao; Huang, Yongwen 分享 收藏
Single-cell RNA sequencing reveals a distinct profile of bone immune microenvironment and decreased osteoclast differentiation in type 2 diabetic mice Wu, Zimei; Hou, Qiaodan; Chi, Heng; Liu, Jihong; Mei, Yixin; Chen, Tingting; Yang, Kunkun; Zheng, Jingna; Xu, Jing; Wei, Fuxin; Wang, Lin 分享 收藏
Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study chiauranib在铂类耐药或难治性卵巢癌联合治疗中的疗效和安全性: 一项多中心,开放标签,Ib和II期研究 Li, Jin; Liu, Jihong; Yin, Rutie; Zou, Dongling; Zheng, Hong; Cao, Junning; Chen, Zhendong; Sun, Wei; Gao, Yunong; Zhang, Songling; Zeng, Linjuan; An, Ruifang; Lu, Xianping; Ye, Shuang; Wu, Xiaohua 分享 收藏
分享 收藏
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): fi nal overall survival analysis of a phase 3 randomised, placebo-controlled trial Wu, Xiaohua; Zhu, Jianqing; Yin, Rutie; Yang, Jiaxin; Liu, Jihong; Wang, Jing; Wu, Lingying; Liu, Ziling; Gao, Yunong; Wang, Danbo; Lou, Ge; Yang, Hongying; Zhou, Qi; Kong, Beihua; Huang, Yi; Chen, Lipai; Li, Guiling; An, Ruifang; Wang, Ke; Zhang, Yu; Yan, Xiaojian; Lu, Xin; Lu, Weiguo; Hao, Min; Wang, Li; Cui, Heng; Chen, Qionghua; Abulizi, Guzhalinuer; Huang, Xianghua; Tian, Xiaofei; Wen, Hao; Huang, Zhao; Dong, Juan; Zhang, Charlie; Hou, Jianmei; Mirza, Mansoor R. 分享 收藏
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer Li, Huayi; Peng, Zikun; Zhu, Jianqing; Zhao, Weidong; Huang, Yi; An, Ruifang; Zheng, Hong; Qu, Pengpeng; Wang, Li; Zhou, Qi; Wang, Danbo; Lou, Ge; Wang, Jing; Wang, Ke; Kong, Beihua; Xie, Xing; Yin, Rutie; Low, John; Rozita, Abdul Malik; Sen, Lim Chun; Meng, Yong Chee; Kiong, Kho Swee; Liu, Jihong; Liang, Zhiqing; Lv, Weiguo; Zhu, Yaping; Hu, Weiguo; Sun, Wei; Su, Jingya; Wang, Qiqi; Zang, Rongyu; Ma, Ding; Gao, Qinglei 分享 收藏
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial Wu, Xiaohua; Liu, Jihong; Wang, Jing; Wang, Li; Lin, Zhongqiu; Wang, Xiaobin; Zhu, Jianqing; Kong, Beihua; Fei, Junwei; Tang, Ying; Xia, Bairong; Liang, Zhiqing; Wang, Ke; Huang, Yi; Zheng, Hong; Lin, An; Jiang, Kui; Wang, Wei; Wang, Xin; Lou, Ge; Pan, Hongming; Yao, Shuzhong; Li, Guiling; Hao, Min; Cai, Yunlang; Chen, Xuejun; Yang, Zhijun; Chen, Youguo; Wen, Hongwu; Qu, Pengpeng; Xu, Cong; Hsieh, Chih-Yi 分享 收藏
分享 收藏
Shanghai Gynecologic Oncology Group's consensus on the academic and industry's clinical trial types Shi, Tingyan; Liu, Jihong; Zhu, Jianqing; Wang, Xipeng; Jiang, Wei; Lu, Xin; Feng, Weiwei; Zhou, Shengtao; Shen, Yang; Chen, Gang; Wu, Zhenyu; Zou, Dongling; Wu, Peng; Yang, Huijuan; Wu, Sufang; Zhu, Tao; Wang, Huaying; Zhang, Yingli; Qiu, Lihua; Guo, Xiaoqing; Xiang, Libing; Zhang, Wei; Ren, Yulan; Feng, Yanling; Liu, Yanfei; Chen, Xiaojun; Zang, Rongyu 分享 收藏
Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study Cai, Guangyao; Huang, Fangjun; Gao, Yue; Li, Xiao; Chi, Jianhua; Xie, Jincheng; Zhou, Linghong; Feng, Yanling; Huang, He; Deng, Ting; Zhou, Yun; Zhang, Chuyao; Luo, Xiaolin; Xie, Xing; Gao, Qinglei; Zhen, Xin; Liu, Jihong 分享 收藏
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study Yan, X. Q.; Yey, M. J.; Zou, Q.; Chen, P.; He, Z. S.; Wu, B.; He, D. L.; He, C. H.; Xue, X. Y.; Ji, Z. G.; Chen, H.; Zhang, S.; Liu, Y. P.; Zhang, X. D.; Fu, C.; Xu, D. F.; Qiu, M. X.; Lv, J. J.; Huang, J.; Ren, X. B.; Cheng, Y.; Qin, W. J.; Zhang, X.; Zhou, F. J.; Ma, L. L.; Guo, J. M.; Ding, D. G.; Wei, S. Z.; He, Y.; Guo, H. Q.; Shi, B. K.; Liu, L.; Liu, F.; Hu, Z. Q.; Jin, X. M.; Yang, L.; Zhu, S. X.; Liu, J. H.; Huang, Y. H.; Xu, T.; Liu, B.; Sun, T.; Wang, Z. J.; Jiang, H. W.; Yu, D. X.; Zhou, A. P.; Jiang, J.; Luan, G. D.; Jin, C. L.; Xu, J.; Hu, J. X.; Huang, Y. R.; Guo, J.; Zhai, W.; Sheng, X. N. 分享 收藏